LRMR

LRMR Investing Cash Flow

$55.11MTTM · USD

Period ending:

LRMR FY Cash from InvestingUSD
LRMR FY Cash from Investing2011-12-31: -$45.00K2012-12-31: -$2.00K2013-12-31: -$17.00K2014-12-31: -$57.32M2015-12-31: -$92.12M2016-12-31: $51.45M2017-12-31: $35.65M2018-12-31: -$6.87M2019-12-31: -$83.00K2020-12-31: $17.09M2021-12-31: $24.17M2022-12-31: -$90.96M2023-12-31: $33.35M2024-12-31: -$85.39M2025-12-31: $100.31M$100.31M-$92.12M
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LRMR investing cash flow history

Cash used for investments in assets and securities. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Larimar Therapeutics Inc Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
100,309,000
-85,387,000
33,353,000
-90,960,000
24,169,000
17,090,000
-83,000
-6,867,000
35,647,000
51,447,000
-92,118,000
-57,315,000
-17,000
-2,000
-45,000

Compare investing cash flow

All LRMR financial metrics · LRMR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.